Complete Response to Aflibercept-FOLFIRI in One Patient With Colorectal Cancer Refractory to Bevacizumab-FOLFOX: A Possible Autocrine Vascular Endothelial Growth Factor Receptor 2-Related Mechanism

Complete Response to Aflibercept-FOLFIRI in One Patient With Colorectal Cancer Refractory to Bevacizumab-FOLFOX: A Possible Autocrine Vascular Endothelial Growth Factor Receptor 2-Related Mechanism

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Colorectal Cancer - Volume 15, Issue 4, December 2016, Pages e229-e234

Stefano Kim, Anne Cayre, Marine Jary, Marion Jacquin, Francine Arbez-Gindre, Francine Fein, Zaher Lakkis, Thierry Nguyen, Christophe Borg,